Nevertheless, the recent studies revealed that TDO could be involved in modulating antitumor immune responses and the antitumor immunotherapy efficacy (60, 61), but it did not colocalize with IDO1, at least, in human glioblastoma (62). The gene discussed is TDO2; the disease is glioblastoma.